Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Liraglutide

Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes

Novo Nordisk · Phase 3 · Completed · Enrollment 3731

NCT01272219

EudraCT 2008-001049-24

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Liraglutide 3.0mg (week0-56)/Liraglutide 3.0mg (week56-68)n/rn/rn/rn/rn/r
Liraglutide 3.0mg (week0-56)/Liraglutide Placebo (week56-68)n/rn/rn/rn/rn/r
Liraglutide Placebo, no Pre-diabetes78 participants25 participants46 participantsn/rn/r
Liraglutide 3.0mg, Pre-diabetesn/rn/rn/rn/rn/r
Liraglutide Placebo, Pre-diabetes128 participants42 participants107 participantsn/rn/r
Liraglutide 3.0 mg (56-Week)622 participants300 participants388 participantsn/rn/r

A count stays a count. This page does not turn a count into a percent.